Targeting NaPi-IIb for Hyperphosphatemia in Chronic Kidney Disease Patients - The Dead End?
作者信息
Apetrii Mugurel, Covic Adrian
机构信息
Nephrology Department, University of Medicine and Pharmacy, "Grigore T. Popa," Iasi, Romania.
出版信息
Kidney Int Rep. 2021 Feb 3;6(3):557-558. doi: 10.1016/j.ekir.2021.01.017. eCollection 2021 Mar.
Abstract
摘要
相似文献
1
Targeting NaPi-IIb for Hyperphosphatemia in Chronic Kidney Disease Patients - The Dead End?以NaPi-IIb为靶点治疗慢性肾脏病患者高磷血症——此路不通？
Kidney Int Rep. 2021 Feb 3;6(3):557-558. doi: 10.1016/j.ekir.2021.01.017. eCollection 2021 Mar.
2
Expression of NaPi-IIb in rodent and human kidney and upregulation in a model of chronic kidney disease.NaPi-IIb 在啮齿动物和人类肾脏中的表达及其在慢性肾脏病模型中的上调。
Pflugers Arch. 2020 Apr;472(4):449-460. doi: 10.1007/s00424-020-02370-9. Epub 2020 Mar 26.
3
Clinical aspects of the phosphate transporters NaPi-IIa and NaPi-IIb: mutations and disease associations.磷酸盐转运蛋白 NaPi-IIa 和 NaPi-IIb 的临床方面：突变与疾病相关性。
Pflugers Arch. 2019 Jan;471(1):137-148. doi: 10.1007/s00424-018-2246-5. Epub 2018 Dec 13.
4
The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease.胃肠道在健康和慢性肾脏病中磷酸盐稳态中的作用。
Curr Opin Nephrol Hypertens. 2013 Jul;22(4):481-7. doi: 10.1097/MNH.0b013e3283621310.
5
EOS789, a novel pan-phosphate transporter inhibitor, is effective for the treatment of chronic kidney disease-mineral bone disorder.EOS789是一种新型的泛磷酸盐转运体抑制剂，对治疗慢性肾脏病-矿物质和骨异常有效。
Kidney Int. 2020 Aug;98(2):343-354. doi: 10.1016/j.kint.2020.02.040. Epub 2020 Apr 23.
6
Evidence of an intestinal phosphate transporter alternative to type IIb sodium-dependent phosphate transporter in rats with chronic kidney disease.在慢性肾脏病大鼠中发现了一种不同于 IIb 型钠依赖性磷酸盐转运体的肠道磷酸盐转运体。
Nephrol Dial Transplant. 2021 Jan 1;36(1):68-75. doi: 10.1093/ndt/gfaa156.
7
Significant Species Differences in Intestinal Phosphate Absorption between Dogs, Rats, and Monkeys.犬、大鼠和猴之间肠道磷酸盐吸收存在显著的物种差异。
J Nutr Sci Vitaminol (Tokyo). 2020;66(1):60-67. doi: 10.3177/jnsv.66.60.
8
Characterization of a type IIb sodium-phosphate cotransporter from zebrafish (Danio rerio) kidney.斑马鱼（Danio rerio）肾脏中IIb型钠-磷酸盐共转运体的特性分析。
Am J Physiol Renal Physiol. 2003 Apr;284(4):F727-36. doi: 10.1152/ajprenal.00356.2002. Epub 2002 Dec 17.
9
Effect of hyperphosphatemia on gene expression of the Na-Pi cotransporter in rats.高磷血症对大鼠钠-磷共转运体基因表达的影响。
Genet Mol Res. 2016 Jan 4;14(4):19404-10. doi: 10.4238/2015.December.30.1.
10
Intestinal Depletion of NaPi-IIb/Slc34a2 in Mice: Renal and Hormonal Adaptation.小鼠肠道中NaPi-IIb/Slc34a2的缺失：肾脏及激素适应性变化
J Bone Miner Res. 2015 Oct;30(10):1925-37. doi: 10.1002/jbmr.2523. Epub 2015 May 7.
引用本文的文献
1
Intestinal phosphorus absorption: recent findings in translational and clinical research.肠道磷吸收：转化和临床研究中的新发现。
Curr Opin Nephrol Hypertens. 2021 Jul 1;30(4):404-410. doi: 10.1097/MNH.0000000000000719.
本文引用的文献
1
NaPi-IIb Inhibition for Hyperphosphatemia in CKD Hemodialysis Patients.钠-磷协同转运蛋白-IIb抑制剂用于慢性肾脏病血液透析患者高磷血症的治疗
Kidney Int Rep. 2020 Dec 23;6(3):675-684. doi: 10.1016/j.ekir.2020.12.017. eCollection 2021 Mar.
2
Evidence of an intestinal phosphate transporter alternative to type IIb sodium-dependent phosphate transporter in rats with chronic kidney disease.在慢性肾脏病大鼠中发现了一种不同于 IIb 型钠依赖性磷酸盐转运体的肠道磷酸盐转运体。
Nephrol Dial Transplant. 2021 Jan 1;36(1):68-75. doi: 10.1093/ndt/gfaa156.
3
NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD.NPT-IIb抑制并不能改善慢性肾脏病患者的高磷血症。
Kidney Int Rep. 2017 Aug 12;3(1):73-80. doi: 10.1016/j.ekir.2017.08.003. eCollection 2018 Jan.
4
Phosphate-a poison for humans?磷酸盐——人类的毒药？
Kidney Int. 2016 Oct;90(4):753-63. doi: 10.1016/j.kint.2016.03.039. Epub 2016 Jun 7.
5
Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study.烟酰胺在血液透析患者中的疗效与安全性：NICOREN研究
Nephrol Dial Transplant. 2017 May 1;32(5):870-879. doi: 10.1093/ndt/gfw042.
6
Serum phosphate and mortality in patients with chronic kidney disease.血清磷酸盐与慢性肾脏病患者的死亡率。
Clin J Am Soc Nephrol. 2010 Dec;5(12):2251-7. doi: 10.2215/CJN.00810110. Epub 2010 Aug 5.
7
Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.烟酸在无肾衰竭患者中的低磷血症作用：一项随机试验。
Clin J Am Soc Nephrol. 2010 Apr;5(4):582-9. doi: 10.2215/CJN.07341009. Epub 2010 Mar 18.
8
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).改善全球肾脏病预后组织（KDIGO）慢性肾脏病-矿物质和骨异常（CKD-MBD）诊断、评估、预防及治疗临床实践指南。
Kidney Int Suppl. 2009 Aug(113):S1-130. doi: 10.1038/ki.2009.188.
9
Niacin lowers serum phosphate and increases HDL cholesterol in dialysis patients.烟酸可降低透析患者的血清磷酸盐水平并提高高密度脂蛋白胆固醇水平。
Clin J Am Soc Nephrol. 2007 Nov;2(6):1249-54. doi: 10.2215/CJN.01470307. Epub 2007 Oct 3.
10
Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine.在哺乳动物小肠中表达的一种小鼠II型钠-磷酸共转运体的特性分析。
Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14564-9. doi: 10.1073/pnas.95.24.14564.
Zotero 插件